89R9017 AB-D
 
  By: VanDeaver H.B. No. 4783
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to a report on governmental opioid antagonist programs to
  reverse and prevent opioid overdoses.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Subchapter B, Chapter 461A, Health and Safety
  Code, is amended by adding Section 461A.060 to read as follows:
         Sec. 461A.060.  BIENNIAL REPORT ON OPIOID ANTAGONIST
  PROGRAMS FOR OPIOID OVERDOSE REVERSAL AND PREVENTION.  (a)  In this
  section, "opioid antagonist" has the meaning assigned by Section
  483.101.
         (b)  Not later than October 1 of each even-numbered year, the
  commission shall:
               (1)  prepare a report evaluating the distribution of
  opioid antagonists in this state to reverse and prevent opioid
  overdoses; and
               (2)  submit the report to the governor, the lieutenant
  governor, and the speaker of the house of representatives.
         (c)  The report described by Subsection (b) must:
               (1)  include a needs assessment for the opioid
  antagonist program established under Section 461A.059;
               (2)  establish a statewide saturation goal for opioid
  antagonists and include:
                     (A)  a description of the data sources and
  methodology used to estimate insufficiencies in the current supply
  of opioid antagonists; and
                     (B)  a communications plan to address opioid
  overdoses in areas of this state at higher risk for increased
  numbers of overdoses;
               (3)  include a description of all state and federal
  money appropriated to the opioid antagonist program established
  under Section 461A.059;
               (4)  establish opioid antagonist distribution
  strategies for this state;
               (5)  list and describe all available state and
  federally funded purchase and distribution programs for opioid
  antagonists; and
               (6)  recommend improvements for addressing opioid
  overdoses among high-risk populations, including school-aged
  children, pregnant and postpartum women, and individuals residing
  in rural areas of this state.
         (d)  In preparing the report under this section, the
  commission shall coordinate and consult with each state agency,
  institution of higher education, and political subdivision of this
  state that receives funding or other resources under Section
  461A.059 for the distribution of opioid antagonists.
         SECTION 2.  This Act takes effect September 1, 2025.